Schwab Long-Term U.S. Treasury ETF (SCHQ)
Live price chart, market sentiment, and community perspectives for Schwab Long-Term U.S. Treasury ETF (AMEX: SCHQ).
Live price chart, market sentiment, and community perspectives for Schwab Long-Term U.S. Treasury ETF (AMEX: SCHQ).
On our desk, we are heavily weighing the macro headwinds facing long-duration debt. While SCHQ offers an exceptionally low expense ratio of 0.03%, we remain cautious about the debasement trade and uncertainties surrounding the U.S. dollar's reserve status. Client allocation to long-term Treasuries requires looking past the low fees to assess whether duration bets are actually protected against structural fiscal pressures.
From a quantitative risk management perspective, SCHQ's current neutral sentiment across all horizons signals a wait-and-see approach. With technical models showing elevated downside risk and limited support signals remaining near current price points around the $30 mark, our playbook suggests avoiding aggressive positioning until a clear price inflection or reversal pattern materializes.
Recent declines in long-term interest rates have been partially driven by weaker economic outlooks and the Supreme Court's tariff decision. However, our fundamental analysis indicates that this catalyst may not be durable and could easily reverse, meaning long-duration Treasury holders like SCHQ investors could face renewed volatility if the policy backdrop shifts.
When evaluating SCHQ against alternative long-term vehicles like Vanguard's VGLT or iShares' TLT during portfolio construction discussions, liquidity is the primary differentiator. SCHQ matches VGLT's 0.03% expense ratio, but TLT boasts massive liquidity that makes it a preferred choice for institutional hedging, tactical trading, and large-scale tax-loss harvesting.
For long-term buy-and-hold retail investors minimizing drag, SCHQ's 0.03% expense ratio is hard to beat compared to TLT's 0.15% fee. However, our risk team always reminds clients that lower fees do not offset liquidity risks during stressed market regimes, where wider bid-ask spreads on smaller asset-under-management funds can erode cost savings.
Explore plasma cleansing, somatic organ swaps, and BCI.